Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fas (TNFRSF6) associated factor 1(CPTC-FAF1-2), 1mg/mL | Login | Fas (TNFRSF6) associated factor 1(CPTC-FAF1-2), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| CD52 (Epididymis-Specific Protein 5) (CD52/2276R), 1mg/mL | Login | CD52 (Epididymis-Specific Protein 5) (CD52/2276R), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| Insulin Receptor Alpha (INSR/2277R), 1mg/mL | Login | Insulin Receptor Alpha (INSR/2277R), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (MUC1/2278R), 1mg/mL | Login | MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (MUC1/2278R), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| HLA-DRB (MHC II)(DA2), 1mg/mL | Login | HLA-DRB (MHC II)(DA2), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| Phospho C-Jun (Thr91, Thr93)(C-J 4C4/1), 1mg/mL | Login | Phospho C-Jun (Thr91, Thr93)(C-J 4C4/1), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| SOX9 / SRY-box 9(SOX9/2287R), 1mg/mL | Login | SOX9 / SRY-box 9(SOX9/2287R), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| SOX9 / SRY-box 9(rSOX9/2288), 1mg/mL | Login | SOX9 / SRY-box 9(rSOX9/2288), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| Human Kappa Light Chain / IGKC (B-Cell Marker) (KLC2289R), 1mg/mL | Login | Human Kappa Light Chain / IGKC (B-Cell Marker) (KLC2289R), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| Parathyroid Hormone (PTH) (N-Terminal) (PTH/2295R), 1mg/mL | Login | Parathyroid Hormone (PTH) (N-Terminal) (PTH/2295R), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| PAX5 / BSAP (Early B-Cell Marker)(rPAX5/2060), 1mg/mL | Login | PAX5 / BSAP (Early B-Cell Marker)(rPAX5/2060), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| MUC18 / CD146 / MCAM (Melanoma Cell Adhesion Molecule) (rMUC18/1130), 1mg/mL | Login | MUC18 / CD146 / MCAM (Melanoma Cell Adhesion Molecule) (rMUC18/1130), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| Smooth Muscle Myosin Heavy Chain (SM-MHC) (MYH11/2303R), 1mg/mL | Login | Smooth Muscle Myosin Heavy Chain (SM-MHC) (MYH11/2303R), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker) (rKRT19/799), 1mg/mL | Login | Cytokeratin 19 (KRT19) (Pancreatic Stem Cell Marker) (rKRT19/799), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| FOXA1 / HNF3A (rFOXA1/1515), 1mg/mL | Login | FOXA1 / HNF3A (rFOXA1/1515), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| NKX2.2 (Neuroendocrine & Ewing s Sarcoma Marker) (rNX2/1523), 1mg/mL | Login | NKX2.2 (Neuroendocrine & Ewing s Sarcoma Marker) (rNX2/1523), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| SOX10 (Melanoma Marker) (SOX10/2311R), 1mg/mL | Login | SOX10 (Melanoma Marker) (SOX10/2311R), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| SOX10 (Melanoma Marker) (rSOX10/1074), 1mg/mL | Login | SOX10 (Melanoma Marker) (rSOX10/1074), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| Rb1 (Tumor Suppressor Protein) (RB1/2313R), 1mg/mL | Login | Rb1 (Tumor Suppressor Protein) (RB1/2313R), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| Cdk2 / p34cdc2 Serine-Threonine Kinase(AN4.3), 1mg/mL | Login | Cdk2 / p34cdc2 Serine-Threonine Kinase(AN4.3), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| ERCC1 / RAD10 (Tumor Progression Marker)(ERCC1/2318), 1mg/mL | Login | ERCC1 / RAD10 (Tumor Progression Marker)(ERCC1/2318), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| FAT1 (FAT atypical cadherin 1)(FAT1-3D7/1), 1mg/mL | Login | FAT1 (FAT atypical cadherin 1)(FAT1-3D7/1), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| Annexin A1 / (Hairy Cell Leukemia Marker)(5E4/1), 1mg/mL | Login | Annexin A1 / (Hairy Cell Leukemia Marker)(5E4/1), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| MyoD1 (Rhabdomyosarcoma Marker) (rMYD712), 1mg/mL | Login | MyoD1 (Rhabdomyosarcoma Marker) (rMYD712), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||
| Cyclin A2 (S- & G2-phase Cyclin)(CCNA2/2333), 1mg/mL | Login | Cyclin A2 (S- & G2-phase Cyclin)(CCNA2/2333), 1mg/mL | ||||||||||||||||
|
||||||||||||||||||


